Cargando…
Intrathecal Methotrexate and Craniospinal Radiotherapy Can Be an Effective Treatment of Carcinomatous Meningitis in Patients with Breast Cancer: Case Reports
INTRODUCTION: Carcinomatous meningitis in breast cancer occurs as a complication in up to 5% of all cases. It is a very devastating diagnosis, with a median patient survival of about 3 months. Treatment is very controversial, and different modalities of treatment have been used but none of them show...
Autores principales: | Meissner, Magdalena, Addeo, Alfredo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118826/ https://www.ncbi.nlm.nih.gov/pubmed/27920689 http://dx.doi.org/10.1159/000449448 |
Ejemplares similares
-
Clinical Improvement and Prolonged Survival With High Dose Intrathecal Methotrexate for Carcinomatous Meningitis Secondary to a Lung Adenocarcinoma
por: Clatot, Florian, et al.
Publicado: (2011) -
Carcinomatous meningitis in non-small cell lung cancer: Palliation with intrathecal treatment
por: Kumar, D. Santhosh, et al.
Publicado: (2014) -
An unusual presentation of carcinomatous meningitis
por: Foo, Chuan T., et al.
Publicado: (2016) -
Ovarian small cell carcinoma complicated by carcinomatous meningitis
por: Kira, Naoko, et al.
Publicado: (2012) -
Radiation Myelopathy Caused by Palliative Radiotherapy and Intrathecal Methotrexate
por: Fukuda, Yukiko, et al.
Publicado: (2022)